STOCK-BASED COMPENSATION (Details 2) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Option Shares
Outstanding at the beginning of the period (in shares)	0	18
Granted (in shares)	21	0
Exercised (in shares)	0	0
Forfeited or expired (in shares)	0	(18)
Outstanding at the end of the period (in shares)	120	0	18
Exercisable at the end of the period (in shares)	99	0
Vested or expected to vest at the end of the period (in shares)	120	0
Net BioSante Stock Options assumed (in shares)	99
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 0	$ 11.00
Granted (in dollars per share)	$ 6.36	$ 0
Exercised (in dollars per share)	$ 0	$ 0
Forfeited or expired (in dollars per share)	$ 0	$ 11.00
Outstanding at the end of the period (in dollars per share)	$ 50.35	$ 0	$ 11.00
Exercisable at the end of the period (in dollars per share)	$ 59.59	$ 0
Vested or expected to vest at the end of the period (in dollars per share)	$ 50.35	$ 0
Net BioSante Stock Options assumed (in dollars per share)	$ 59.59
Weighted Average Remaining Term
Outstanding at the end of the period weighted average remaining term	2 years 4 months 24 days		6 years 2 months 12 days
Exercisable at the end of the period weighted average remaining term	10 months 24 days	0 years
Vested or expected to vest at the end of the period weighted average remaining term	2 years 4 months 24 days	0 years
Aggregate Intrinsic Value
Exercised at the end of the period intrinsic value (in dollars)	$ 0	$ 0
Outstanding at the end of the period intrinsic value (in dollars)	81	0
Exercisable at the end of the period intrinsic value (in dollars)	0	0
Vested or expected to vest at the end of the period intrinsic value (in dollars)	$ 81	$ 0